Chicago Atlantic Real Estate Finance, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026, with the SEC on November 10, 2026, reporting third-quarter net income of $6,434,023 and total assets of $468,192,211.
Protalix BioTherapeutics, Inc. filed a Form 10-Q with the SEC on November 10, 2026, reporting unaudited condensed consolidated financial results for the quarterly period ended September 30, 2026.
Boundless Bio, Inc. filed its quarterly report on Form 10-Q with the SEC on November 10, 2026, covering the three-month period ended September 30, 2026, and disclosing a pending merger with Serapha Bio, Inc. as a central development.
Chicago Atlantic Real Estate Finance, Inc. filed a Form 8-K on November 10, 2026, announcing its financial results for the third quarter ended September 30, 2026, and disclosing materials related to its proposed merger with Chicago Atlantic BDC, Inc.
Liquidia Corporation filed a current report on November 10, 2026, disclosing the issuance of a press release covering its financial results for the quarter ended September 30, 2026, and the filing of an updated corporate presentation for use at healthcare conferences and investor meetings.
● Fiscal 2026Revenuewas $2.29 million, down about 30%.
● Net loss was $9.48 million against a marginal profit in 2024.
● Adjusted EBITDA for the half was about $2.2 million.
● The company raised $8 million in a June 2026 registered direct offering.
● Cash was US$6.61 million at June 30, 2026.